Diagnostic utility of glycosyltransferase mRNA expression in gastric cancer

Showkat, 2015, Environmental factors in etiology of gastric cancer, Adv Biochem, 3, 51, 10.11648/j.ab.20150305.11 Baniak, 2016, Gastric biomarkers: a global review, World J Surg Oncol, 14, 212, 10.1186/s12957-016-0969-3 Lin, 2015, Molecular classification and prediction in gastric cancer, Comput Struct Biotechnol J, 13, 448, 10.1016/j.csbj.2015.08.001 Nissar, 2017, Diagnostic utility of DAPK-gene promoter hypermethylation in gastric cancer, Int J Sci Inventions Today, 5, 646 Ozcan, 2013, Serum glycan signatures of gastric cancer, Cancer Prev Res, 7, 226, 10.1158/1940-6207.CAPR-13-0235 Kuzmanov, 2013, The sweet and sour of serological glycoprotein tumor biomarker quantification material and methods, BMC Med, 11, 31, 10.1186/1741-7015-11-31 Liang, 2007, Enzymes and related proteins as cancer biomarkers: A proteomic approach, Clin Chim Acta, 381, 93, 10.1016/j.cca.2007.02.017 Meany, 2009, Early detection of cancer: Immunoassays for plasma tumor markers, Expert Opin Med Diagn, 3, 597, 10.1517/17530050903266830 Dennis, 1999, Glycoprotein glycosylation and cancer progression, Biochim Biophys Acta, 1473, 21, 10.1016/S0304-4165(99)00167-1 Fuster, 2005, The sweet and sour of cancer: Glycans as novel therapeutic targets, Nat Rev Cancer, 5, 526, 10.1038/nrc1649 Dube, 2005, Glycans in cancer and inflammation–potential for therapeutics and diagnostics, Nat Rev Drug Discov, 4, 477, 10.1038/nrd1751 Drake, 2010, Sweetening the pot: Adding glycosylation to the biomarker discovery equation, Clin Chem, 56, 223, 10.1373/clinchem.2009.136333 Fukuda, 1996, Possible roles of tumor-associated carbohydrate antigens, Cancer Res, 56, 2237 Brooks, 2007, Immunolocalisation of members of the polypeptide N-acetylgalactosaminyl transferase (ppGalNAc-T) family is consistent with biologically relevant altered cell surface glycosylation in breast cancer, Acta Histochem, 109, 273, 10.1016/j.acthis.2007.02.009 Dong, 2012, Polypeptide N-acetylgalactosaminyltransferase 2 regulates cellular metastasis-associated behavior in gastric cancer, Int J Mol Med, 30, 1267, 10.3892/ijmm.2012.1130 Abelev, 1963, Production of embryonal alpha-globulin by transplantable mouse hepatomas, Transplantation, 1, 174, 10.1097/00007890-196301020-00004 S. Sell, Tumor Markers: Physiology, Pathobiology, Technology and Clinical Applications. Eleftherios P. Diamandis, Hervert A. Fritche, Hans Lilja, Daniel W. Chan, and Morton K. Schwartz, (Eds.), Washington, DC: AACC Press, 2002, 513 pp., $99.00 ($79.00 AACC members). Clinical Chemistry, 49:2, 342. https://doi:10.1373/49.2.342. Bast, 1981, Reactivity of a monoclonal antibody with human ovarian carcinoma, J Clin Invest, 68, 1331, 10.1172/JCI110380 Bagshawe, 1980, Markers in gynaecological cancer, Arch Gynecol, 229, 303, 10.1007/BF02108581 Meany, 2011, Aberrant glycosylation associated with enzymes as cancer biomarkers, Clin Proteom, 8, 7, 10.1186/1559-0275-8-7 Picco, 2010, Overexpression of ST3Gal-I promotes mammary tumorigenesis, Glycobiology, 20, 1241, 10.1093/glycob/cwq085 Fukushima, 2010, Alpha 1, 2-fucosylated and beta-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer, Glycobiology, 20, 452, 10.1093/glycob/cwp197 Jankovic, 2008, Glycoforms of CA125 antigen as a possible cancer marker, Cancer Biomark, 4, 35, 10.3233/CBM-2008-4104 Saeland, 2012, Differential glycosylation of MUC1 and CEACAM5 between mucosa and tumour tissue of colon cancer patients, Int J Cancer, 131, 117, 10.1002/ijc.26354 Petretti, 1999, Altered mRNA expression of glycosyltransferases in human gastric carcinomas, Biochim Biophys Acta, 1428, 209, 10.1016/S0304-4165(99)00080-X Hua, 2012, Polypeptide N-acetylgalactosaminyltransferase 2 regulates cellular metastasis-associated behavior in gastric cancer, Int J Mol Med, 30, 1267, 10.3892/ijmm.2012.1130 Marcos, 2003, Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines, J Histochem Cytochem, 51, 761, 10.1177/002215540305100607 Marcos, 2011, ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues, Front Biosci (Elite Ed), 3, 1443 Jun, 2012, Altered mRNA expressions of sialyltransferases in human gastric cancer tissues, Med Oncol, 29, 84, 10.1007/s12032-010-9771-1 Freire, 2006, UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (ppGalNAc-T6) mRNA as a potential new marker for detection of breast cancer cells, Int J Cancer, 119, 1383, 10.1002/ijc.21959 Patani, 2008, Prognostic utility of glycosyltransferase expression in breast cancer, Cancer Genom Proteom, 5, 333 Freire, 2006, UDP-N-acetyl-D galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (ppGalNAc-T1) mRNA as a potential new marker for detection of bone marrow-disseminated breast cancer cells, Int J Cancer, 119, 1383, 10.1002/ijc.21959 Dallolio, 2001, Sialyltransferases in cancer, Glycoconj J, 18, 841, 10.1023/A:1022288022969 Zhu, 2001, Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro, Biochim Biophys Acta, 1536, 148, 10.1016/S0925-4439(01)00044-8 Wang, 2005, Altered mRNA expression of sialyltransferases in ovarian cancers, Gynecol Oncol, 99, 631, 10.1016/j.ygyno.2005.07.016 Picco, 2010, Overexpression of ST3Gal-I promotes mammary tumorigenesis, Glycobiology, 20, 10.1093/glycob/cwq085 Burchell, 1999, An alpha 2,3sialyltransferase (ST3Gal I) elevated in primary breast carcinoma, Glycobiology, 9, 1307, 10.1093/glycob/9.12.1307 Livak, 2001, Analysis of Relative Gene Expression Data Using RealTime Quantitative PCR and the 2- ΔΔCT Method, Method, 25, 402, 10.1006/meth.2001.1262